Palmqvist S et al JAMA Neurology. 2014 Importance: Before adding cerebrospinal fluid (CSF) biomarkers to the diagnostic workup of Alzheimer disease, it needs to be determined whether CSF biomarkers analyzed in routine clinical practice can reliably predict cortical beta-amyloid (Abeta) deposition. Objectives: To study whether CSF biomarkers, analyzed consecutively in routine clinical practice during 2 years, […]